• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Anti-obesity drug users face significant weight rebound after stopping treatment

Anti-obesity drug users face significant weight rebound after stopping treatment

anti-obesity, GLP-1, semaglutide, weight-loss, 22 July 2025/in E-News, obesity, pharmacology /by panglobal

A comprehensive meta-analysis reveals that patients prescribed anti-obesity medications experience substantial weight regain starting eight weeks after discontinuing treatment, with the rebound effect continuing for an average of 20 weeks before stabilising. The research highlights critical challenges in long-term weight management strategies.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/07/ozempic.jpg 514 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-07-22 07:51:042025-07-22 07:51:04Anti-obesity drug users face significant weight rebound after stopping treatment
Brain

Digital test breakthrough links brain chemistry to cognitive health

brain chemistry, cognitive health, 18 July 2025/in E-News, Neurology /by panglobal

A revolutionary digital assessment that measures brain chemistry in just three minutes has been validated against direct neuroimaging for the first time, offering new possibilities for early detection of cognitive decline and dementia. The breakthrough research demonstrates that a self-administered computerised test can accurately reflect levels of acetylcholine, a crucial neurotransmitter whose decline signals cognitive […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/06/brain_waves.jpeg 927 1200 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-07-18 08:00:002025-07-16 11:05:38Digital test breakthrough links brain chemistry to cognitive health
Bill Gates

Global protein study reveals new biomarkers for Alzheimer’s disease

Alzheimer’s, collaboration, 17 July 2025/in dementia, E-News, Research /by panglobal

A landmark international collaboration has created one of the world’s largest protein datasets, analysing 250 million protein measurements from over 35,000 biofluid samples to identify novel biomarkers for Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions that affect 57 million people globally.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/07/Bill_Gates.jpg 1447 960 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-07-17 08:00:132025-07-16 10:56:09Global protein study reveals new biomarkers for Alzheimer’s disease

Medical tourism for weight loss surgery requires urgent global regulation

bariatric surgery, medical tourism, obesity, 16 July 2025/in E-News, Surgery /by panglobal

A new commentary in BMJ Global Health calls for immediate international regulation of bariatric surgery medical tourism, highlighting significant safety, ethical, and legal risks despite the industry’s rapid growth and potential benefits for obesity treatment access.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/07/bariatric_surgery.jpg 312 820 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-07-16 08:00:592025-07-14 08:58:37Medical tourism for weight loss surgery requires urgent global regulation
liquid biopsy test to detect early-stage colorectal cancer

Revolutionary liquid biopsy detects early colorectal cancer via RNA

biopsy, colorectal cancer, RNA, 15 July 2025/in E-News, Oncology /by panglobal

Researchers at the University of Chicago have pioneered a groundbreaking liquid biopsy technique that analyses RNA modifications from gut microbes in blood samples to detect early-stage colorectal cancer with 95% accuracy. The innovative LIME-seq method represents a significant advance over current non-invasive testing approaches, offering unprecedented sensitivity for identifying the disease at its most treatable […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/07/colon_cancer_14.jpg 538 960 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-07-15 08:00:092025-07-14 08:48:40Revolutionary liquid biopsy detects early colorectal cancer via RNA
osteoporosis

AI system detects osteoporosis from routine X-rays

osteoporosis, 14 July 2025/in AI, E-News /by panglobal

Researchers have developed an artificial intelligence system that can estimate bone mineral density and detect osteoporosis from standard lumbar X-ray images, achieving sensitivity rates of 86.4% for osteopenia detection. The technology could transform routine clinical X-rays into powerful screening tools for bone health assessment.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/07/osteoporosis.png 397 706 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-07-14 08:00:432025-07-11 10:52:50AI system detects osteoporosis from routine X-rays
Consultant radiologist and Chairman of Marris Medical, Dr Ammad Hussain

New Harley Street diagnostics clinic opens with the support of equipment and finance from Siemens

Harley Street, Siemens, 11 July 2025/in E-News /by panglobal

Marris Medical is offering high-quality diagnostic imaging, as well as an ‘office-based laboratory’ for a range of minimally invasive procedures, improving access to care. Finance from Siemens Financial Services (SFS) and equipment from Siemens Healthineers was integral to the clinic’s launch in the UK.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/07/Dr-Ammad-Hussain.jpg 1280 960 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-07-11 10:43:572025-07-11 10:43:57New Harley Street diagnostics clinic opens with the support of equipment and finance from Siemens
alzheimers

New stem cell bank enables global Alzheimer’s research

Alzheimer’s disease, stem cells, 9 July 2025/in dementia, E-News, Genetics /by panglobal

A groundbreaking stem cell repository has been established using blood samples from over 100 individuals selected for their extreme genetic risk profiles for Alzheimer’s disease. The IPMAR resource will enable researchers worldwide to study how genetic variants contribute to the neurodegenerative condition in laboratory models.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/05/alzheimers.jpg 846 1310 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-07-09 10:07:192025-07-09 10:07:19New stem cell bank enables global Alzheimer’s research
callan emery / Midjourney

DNA-guided prescribing shows major clinical impact in NHS trial

genome, prescription, 9 July 2025/in E-News, Genetics, Research /by panglobal

A major NHS study has demonstrated that pharmacogenomic testing can be successfully integrated into routine clinical practice, with genomic data seamlessly incorporated into electronic health records to guide safer prescribing decisions. The PROGRESS programme showed that 95% of patients carried actionable genetic variants related to common medications, leading to prescription adjustments in over a quarter […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/05/genome_prescription.jpg 600 600 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-07-09 08:00:462025-07-09 09:50:28DNA-guided prescribing shows major clinical impact in NHS trial
Professor Heyo K. Kroemer, Charité Executive Board Chairman and Bernd Montag, Siemens Healthineers Chief Executive sign the strategic cooperation agreement.

Siemens Healthineers partners with Charité for preventive medicine research

Charite, preventive medicine, Siemens, 8 July 2025/in E-News, Research /by panglobal

Germany’s leading medical technology company Siemens Healthineers has announced a strategic cooperation agreement with Charité – Universitätsmedizin Berlin to develop innovative preventive medicine concepts, with an initial focus on cardiovascular disease prevention through advanced imaging and artificial intelligence technologies.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/07/siemens-healthineers-press-charit-.jpeg 563 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-07-08 11:35:402025-07-08 11:35:40Siemens Healthineers partners with Charité for preventive medicine research
Page 2 of 233‹1234›»

Latest issue of International Hospital

April 2024

8 August 2025

NEFECON receives Chinese approval for expanded IgA nephropathy treatment

7 August 2025

25-year study reveals how SuperAgers defy cognitive decline

6 August 2025

15 minutes in city green space proves powerful antidote to anxiety and depression

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription